# Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors

> **NCT06713148** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 42 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumor

## Interventions

- **BIOLOGICAL:** IDOV-SAFETM

## Key facts

- **NCT ID:** NCT06713148
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06713148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06713148, "Study on the Safety and Efficacy of Intratumoral Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06713148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*